StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) KPIs and segments

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$400.84−33.09 (-7.63%)

Close on Nov 18, 2026Market cap $86.60BP/E 17.1Yield –

KPI & bộ phận

Chỉ số vận hành và bộ phận làm nên hoạt động của Elevance Health · năm tài chính kết thúc ngày 31 tháng 12

Nhìn nhanh KPI của Elevance Health: 82 chỉ số vận hành, trong đó có Total Medical Membership, Specialty Membership — Vision Members và Specialty Membership — Dental Members, lấy từ 381 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.

Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.

Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.

Thêm vào biểu đồChỉ số
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Carelon Services2
Service fees($M)
206207203180191232223196201196197186
Product revenue($M)
000000000000
CarelonRx2
Product revenue($M)
6,4546,2646,2256,4606,1596,0425,8096,7145,8875,5304,4995,394
Service fees($M)
134244312112
Corporate & Other2
Service fees($M)
0000000-101741
Product revenue($M)
000000000000
Health Benefits2
Service fees($M)
2,0752,0732,0381,9791,9421,8721,8431,8381,8302,0631,8761,733
Product revenue($M)
000000000000
Product revenue($M)
6,4546,2646,2256,4606,1596,0425,8096,7145,8875,5304,4995,394
Service fees($M)
2,2822,2832,2452,1612,1372,1082,0692,0302,0232,2772,0781,922
CarelonRx($M)
616582582724556536602533619497523490
Health Benefits($M)
4368962,157-2206011,5602,2172071,6042,1452,287767
Carelon Services($M)
292366470-15021940049135184208290102
Corporate & Other($M)
-75-81-1,123-45-81-71-140-102-999-85-84-75
Kỳ báo cáo trước đây (báo cáo lần cuối 2023)1
Total Medical Membership5
44,882.0044,949.0045,418.0045,232.0045,369.0045,621.0045,833.0045,734.0045,760.0045,776.0046,049.0046,829.00
Commercial Fee-Based Medical Membership (Self-Funded & BlueCard®)2
27,605.0027,513.0027,749.0027,092.0027,002.0027,154.0027,130.0027,199.0027,266.0027,234.0027,257.0026,933.00
Employer Group Fee-Based Medical Membership (Self-Funded / ASO)
21,009.0020,931.0021,170.0020,583.0020,608.0020,584.0020,522.0020,569.0020,589.0020,542.0020,622.0020,227.00
BlueCard® Host Medical Membership
6,596.006,582.006,579.006,509.006,394.006,570.006,608.006,630.006,677.006,692.006,635.006,706.00
Commercial Risk-Based Medical Membership (Fully-Insured)2
4,714.004,734.004,863.004,924.004,970.004,963.005,061.005,000.004,971.004,929.004,894.004,781.00
Employer Group Risk-Based Medical Membership
3,366.003,417.003,439.003,617.003,616.003,615.003,638.003,713.003,672.003,648.003,648.003,756.00
Individual Medical Membership (ACA Marketplace & Off-Exchange)
1,348.001,317.001,424.001,307.001,354.001,348.001,423.001,287.001,299.001,281.001,246.001,025.00
Medicaid Managed Care Medical Membership (TANF, Expansion, ABD & LTSS)
8,220.008,358.008,456.008,500.008,645.008,733.008,862.008,917.008,926.009,028.009,327.0010,503.00
Total Medicare Medical Membership2
2,796.002,790.002,787.003,112.003,122.003,129.003,131.002,957.002,941.002,925.002,913.002,970.00
Medicare Advantage Membership (Part C Individual & Group)
1,898.001,897.001,899.002,230.002,245.002,255.002,255.002,066.002,047.002,031.002,017.002,047.00
Medicare Supplement (Medigap) Membership
898.00893.00888.00882.00877.00874.00876.00891.00894.00894.00896.00923.00
Federal Employee Program (FEP® / FEHB) Medical Membership
1,547.001,554.001,563.001,604.001,630.001,642.001,649.001,661.001,656.001,660.001,658.001,642.00
Specialty Membership — Vision Members
11,895.0011,912.0011,975.0010,842.0010,770.0010,817.0010,419.0010,382.0010,275.0010,251.009,944.00
Specialty Membership — Dental Members1
7,445.007,480.007,556.007,364.007,346.007,394.007,282.007,021.007,008.006,970.006,820.00
Specialty Membership — Dental Administration Members (Network / Third-Party)
1,932.001,940.001,944.001,957.001,961.001,966.001,887.001,878.001,851.001,841.001,729.00
Specialty Membership — Medicare Part D Standalone Members
79.0078.0077.00217.00219.00221.00256.00258.00260.00262.00260.00
CarelonRx — Quarterly Adjusted Prescription Scripts(M)
82.680.980.388.58583.383.982.980.278.27778
Carelon Services — Consumers Served(M)
9192.492.991.897.697.399.5101101102103103
Total Consolidated Operating Revenue (Reportable Segments)($M)4
50,44049,82649,49449,31150,08749,42148,76544,98944,71943,22342,27342,454
Health Benefits Segment — Total Operating Revenue($M)8
43,35742,72042,49041,83542,24641,58241,43137,58038,27837,15937,25836,547
Health Benefits Operating Revenue — Commercial (Group & Individual)($M)1
13,34313,56113,23812,74712,84912,45312,35211,85111,639
of which: Individual (ACA) Health Benefits Operating Revenue($M)
2,5142,7202,5402,2482,3582,3282,3612,1172,082
Health Benefits Operating Revenue — Medicaid($M)
14,97914,44414,28014,50014,16613,91114,04312,75513,063
Health Benefits Operating Revenue — Medicare($M)
11,22910,96210,99110,76211,13811,44611,4069,0549,385
Health Benefits Operating Revenue — Federal Employee Program (FEP®)($M)
3,8063,7533,9813,8264,0933,7723,6303,9204,191
Health Benefits — Premiums Revenue (Note 13 / Note 20)($M)
41,28240,64740,45239,85640,30439,71039,58835,74236,44835,09635,38234,814
Health Benefits — Administrative Service Fees Revenue (Note 13 / Note 20)($M)
2,0752,0732,0381,9791,9421,8721,8431,8381,8302,0631,8761,733
Health Benefits — Segment Benefit Expense (ASU 2023-07)($M)
37,62536,73935,45337,16436,84535,48734,39333,04232,72430,43730,500
Health Benefits — Segment Operating Expense (ASU 2023-07)($M)
5,2965,0854,8804,8914,8004,5354,8214,3313,9504,5774,471
Total Carelon (CarelonRx + Carelon Services) — Operating Revenue($M)7
19,30719,22517,96518,65918,32118,08416,65214,74613,78113,31912,07612,401
CarelonRx Segment — Total Operating Revenue($M)4
11,59911,25010,60011,64410,99710,64310,1169,9779,1438,7748,0678,827
CarelonRx — Unaffiliated (External Third-Party) Operating Revenue($M)
6,4556,2676,2296,4626,1636,0465,8126,7155,8895,5314,5005,396
CarelonRx — Affiliated (Intersegment) Operating Revenue($M)
5,1444,9834,3715,1824,8344,5974,3043,2623,2543,2433,5673,431
CarelonRx — Cost of Products Sold (incl. Intersegment, ASU 2023-07)($M)
10,77910,4739,83010,70010,2099,8849,2849,2298,3368,0407,373
CarelonRx — Segment Operating Expense (ASU 2023-07)($M)
204195188220232223230215188237171
Carelon Services Segment — Total Operating Revenue($M)6
7,7087,9757,3657,0157,3247,4416,5364,7694,6384,5454,0093,574
Carelon Services — Unaffiliated (External Third-Party) Operating Revenue($M)
8751,0409821,3701,9532,0951,723944881990605604
Carelon Services — Affiliated (Intersegment) Operating Revenue($M)
6,8336,9356,3835,6455,3715,3464,8133,8253,7573,5553,4042,970
Carelon Services — Premiums Revenue (Risk-Based Capitation)($M)
6698337791,1901,7621,8631,500748680794408418
Carelon Services — Service Fees Revenue($M)
206207203180191232223196201196197186
Carelon Services — Segment Benefit Expense (incl. Intersegment, ASU 2023-07)($M)
6,5216,7436,0856,3256,3496,2905,3193,9793,7673,6323,010
Carelon Services — Segment Operating Expense (ASU 2023-07)($M)
895866810840756751726755687705709
Total Carelon — Unaffiliated (External Third-Party) Operating Revenue($M)
7,3307,3077,2117,8328,1168,1417,5357,6596,7706,5215,1056,000
Total Carelon — Affiliated (Intersegment) Operating Revenue($M)
11,97711,91810,75410,82710,2059,9439,1177,0877,0116,7986,9716,401
Total Carelon — Segment Benefit Expense (ASU 2023-07)($M)
6,5216,7436,0856,3256,3496,2905,3193,9793,7673,6323,010
Total Carelon — Cost of Products Sold (ASU 2023-07)($M)
10,77910,4739,83010,70010,2099,8849,2849,2298,3368,0407,373
Total Carelon — Segment Operating Expense (ASU 2023-07)($M)
1,0991,0619981,060988974956970875942880
Corporate & Other — Operating Revenue($M)
664-83149232165-1474122127181
Intersegment Operating Revenue Eliminations($M)
-12,230-12,125-10,965-11,100-10,629-10,477-9,483-7,323-7,414-7,377-7,188-6,675
Total Reportable Segments — GAAP Operating Gain($M)4
1,2691,7632,0863091,2952,4253,1706731,4082,7653,0161,284
Total Reportable Segments — Adjusted Operating Gain (Non-GAAP)($M)
1,3371,8183,2043751,3442,4883,2558412,4592,9013,1261,358
Non-GAAP Adjustment Items to Reportable Segments Operating Gain($M)
68551,118664963851681,05113611074
Health Benefits Segment — GAAP Operating Gain (Loss)($M)1
4368962,157-2206011,5602,2172071,6042,1452,287767
Health Benefits — GAAP Operating Margin (%)(%)
1.0%2.1%5.1%-0.5%1.4%3.8%5.4%0.6%4.2%5.8%6.1%2.1%
Total Carelon — GAAP Operating Gain($M)3
9089481,0525747759361,093568803705813592
CarelonRx Segment — GAAP Operating Gain($M)1
616582582724556536602533619497523490
CarelonRx — GAAP Operating Margin (%)(%)
5.3%5.2%5.5%6.2%5.1%5.0%6.0%5.3%6.8%5.7%6.5%5.6%
Carelon Services Segment — GAAP Operating Gain (Loss)($M)1
292366470-15021940049135184208290102
Carelon Services — GAAP Operating Margin (%)(%)
3.8%4.6%6.4%-2.1%3.0%5.4%7.5%0.7%4.0%4.6%7.2%2.9%
Total Carelon — GAAP Operating Margin (%)(%)
4.7%4.9%5.9%3.1%4.2%5.2%6.6%3.9%5.8%5.3%6.7%4.8%
Benefit Expense Ratio (BER / Medical Loss Ratio — % of Premiums)(%)
90.6%89.7%86.8%93.5%91.3%88.9%86.4%92.4%89.5%86.3%85.6%89.2%
Days in Claims Payable (DCP)(ngày)
454547414344444343454947
GAAP Operating Expense Ratio (% of Operating Revenue)(%)1
11.4%11.1%12.8%11.0%10.5%10.1%10.9%10.7%11.8%11.7%11.6%11.8%
Adjusted Operating Expense Ratio (Non-GAAP — % of Operating Revenue)(%)
11.3%11.0%10.5%10.8%10.4%10.0%10.7%10.3%9.4%11.4%11.3%11.6%
Consolidated GAAP Operating Margin (% of Operating Revenue)(%)2
2.5%3.5%4.2%0.6%2.6%4.9%6.5%1.5%3.1%6.4%7.1%3.0%
Consolidated Adjusted Operating Margin (Non-GAAP — % of Operating Revenue)(%)
2.7%3.6%6.5%0.8%2.7%5.0%6.7%1.9%5.3%6.7%7.4%3.2%
GAAP Pretax Income Margin (% of Total Revenue)(%)
3.5%3.8%4.6%0.4%2.8%4.6%5.7%1.3%3.0%6.8%6.9%2.3%
Gross Medical Claims Payable, Ending Balance($M)3
18,43818,46318,42517,08417,14817,15516,81215,74615,34615,20416,45916,111
Net Medical Claims Payable, Ending Balance($M)
18,04918,10018,07416,78116,82416,85516,51515,56715,17615,05516,17515,858
Ceded Medical Claims Payable (Reinsurance Recoverable)($M)
454445484416141391287
Other Policyholder Liabilities & Future Policy Benefits($M)
2,6353,4633,8573,6322,4473,5403,7964,2044,4024,9395,2985,600
Total Net Incurred Medical Claims($M)2
36,76535,99534,55337,11937,13235,73734,28832,53432,02729,57529,50330,511
Net Incurred Medical Claims — Current Incurred Year($M)
36,86536,06635,67737,14337,33335,77735,31332,65532,16429,84330,70830,740
Net Incurred Medical Claims — Prior Years Redundancies (Favorable Reserve Development)($M)
-100-71-1,124-24-201-40-1,025-121-137-268-1,205-229
Total Net Medical Claim Cash Payments($M)3
36,81635,96933,26037,16237,32535,66433,25532,28631,90630,69529,18630,566
Net Medical Claim Payments — Current Incurred Year($M)
35,80633,60023,01036,72036,42833,72523,39231,71030,92328,71719,58030,098
Net Medical Claim Payments — Prior Incurred Years($M)
1,0102,36910,2504428971,9399,8635769831,9789,606468
Medical Claims Payable Added via Business Combinations($M)
0000162267-851430000
IBNR + Expected Development on Reported Claims — Current Claim Year($M)2
16,19215,13312,66715,64515,22314,15411,83514,58313,49512,25411,12814,652
IBNR + Expected Development on Reported Claims — Prior Claim Year (t-1)($M)
1,4452,4194,6538291,2582,2473,9797921,3962,3494,323843
IBNR + Expected Development on Reported Claims — Older Claim Years (t-2 & Prior)($M)
412548754307343454701192285452724363
Parent Company Cash and Investments (Quarterly 8-K Disclosure)($M)
2,4002,1002,2002,6002,6002,2001,4002,4002,6002,4001,0001,600
Common Stock Repurchased and Retired — Total Cost($M)3
3302341,1244718753798801,81160463566950
Common Stock Repurchased — Quarterly Volume (8-K)(M)
0.800.703.701.402.900.902.204.500.100.901.102
Common Stock Repurchased — Weighted-Average Price per Share (8-K)($)
399345305336303410396401511525493466
Board-Approved Share Repurchase Authorization Remaining($M)
5,0075,3375,5716,6957,1668,0418,4209,3003,1113,1713,6334,200
AFS Fixed Maturity Securities — Total Fair Value($M)8
26,55826,97827,01927,00527,39426,38526,49726,23629,84729,74930,41030,490
AFS Fixed Maturity Securities — Amortized Cost($M)
28,07827,22527,29826,88927,31026,59026,88326,92829,62230,70131,32931,336
AFS Fixed Maturity Securities — Gross Unrealized Gains($M)
95388387631639477367284901313384496
AFS Fixed Maturity Securities — Gross Unrealized Losses($M)
1,5555806114945426677469706741,2611,2991,338
AFS Fixed Maturity by Maturity — Due in 1 Year or Less (Fair Value)($M)
289272200238279294196196259197365470
AFS Fixed Maturity by Maturity — Due in 1 to 5 Years (Fair Value)($M)
3,1673,5813,8484,3054,8904,7124,6474,7725,1175,3765,9007,193
AFS Fixed Maturity by Maturity — Due in 5 to 10 Years (Fair Value)($M)
8,9729,2739,40010,69710,58010,45410,57810,37811,62711,05510,86410,325
AFS Fixed Maturity by Maturity — Due After 10 Years (Fair Value)($M)
5,9795,7855,4736,5856,4085,8785,7856,0907,1067,3697,4606,624
AFS Fixed Maturity by Maturity — Mortgage-Backed Securities (Fair Value)($M)
8,1518,0678,0985,1805,2375,0475,2914,8005,7385,7525,8215,878
AFS Securities in Continuous Unrealized Loss Position (≥ 12 Months) — Fair Value($M)2
2,7723,3263,6564,2084,7575,3215,9716,6498,11810,91912,09714,842
Unrealized Loss Position (≥ 12 Months) — Gross Unrealized Loss($M)
5424284414234105396207526561,1231,1991,283
AFS Securities in Continuous Unrealized Loss Position (< 12 Months) — Fair Value($M)1
20,5089,3389,0413,5942,8514,4676,2429,2138227,9645,8552,699
Unrealized Loss Position (< 12 Months) — Gross Unrealized Loss($M)
1,013152170711321281262181813810055
Long-Term Other Invested Assets (Private Equity, Real Estate & Partnerships)($M)3
11,50811,13011,00910,83910,64810,46610,1679,7499,3946,8106,7136,107
Marketable Equity Securities — Fair Value($M)
2,1511,5631,5117401,2209347151,1921,113594511229
Restricted Cash and Investments($M)
500668527348397519695409339400499294
Accrued Investment Income Receivable($M)
308322299295280284268287300316294301
Long-Term Debt, Less Current Portion — Carrying Value($M)2
30,38230,66930,76830,79731,17328,17828,11029,21824,68824,56121,97623,246
Long-Term Debt — Current Portion($M)
3753753501,0997491,6481,6431,6492,1002,9002,9001,649
Short-Term Borrowings (FHLB Advances)($M)
007241501803602503653602251,575225
Total Undiscounted Operating Lease Payments1
Effective Income Tax Rate (%)(%)
25.1%24.9%23.6%15.6%23.9%21.9%26.6%22.9%23.5%
Elevance Health (ELV) vs. Managed Care Peers — Total Consolidated Revenues($M)6
51,42950,47450,18149,74750,71149,77648,89145,44245,10643,88642,57742,647
UnitedHealth Group (UNH) — Total Consolidated Revenues($M)
112,032111,721113,215113,161111,616109,575100,807100,82098,85599,79694,427
CVS Health / Aetna (CVS) — Total Consolidated Revenues($M)
106,096100,426105,693102,87198,91594,58897,71095,42891,23488,43793,813
The Cigna Group (CI) — Total Consolidated Revenues($M)
71,66868,49472,47269,74867,17865,50265,64963,69460,52357,25551,114
Humana Inc. (HUM) — Total Consolidated Revenues($M)
39,64832,51532,64932,38832,11229,21329,39729,54029,61126,462
Centene Corporation (CNC) — Total Consolidated Revenues($M)
50,64753,57949,94449,72549,69048,74246,62040,80542,02339,83640,40739,460
Molina Healthcare (MOH) — Total Consolidated Revenues($M)
11,08210,87410,79611,37511,47711,42711,14710,49910,3409,8809,9319,048
Elevance Health (ELV) vs. Managed Care Peers — Insurance Premiums Revenue($M)5
41,70441,27941,02440,69041,79141,27140,88736,24536,80935,41635,69635,138
UnitedHealth Group (UNH) — Insurance Premiums Revenue($M)
86,95687,56188,81188,97987,90586,53476,48377,44276,89777,98873,228
CVS Health / Aetna (CVS) — Insurance Premiums Revenue($M)
35,11733,79134,01733,71934,19532,82030,91330,92530,66730,39125,075
The Cigna Group (CI) — Insurance Premiums Revenue($M)
9,8599,8129,2889,0819,15612,73611,50311,43611,45411,60311,175
Humana Inc. (HUM) — Insurance Premiums Revenue($M)
37,70930,88430,71130,71630,51427,75027,95128,14228,26125,128
Molina Healthcare (MOH) — Insurance Premiums Revenue($M)
10,45710,24410,17210,71510,84110,86810,6289,9839,6949,4469,5048,362
Elevance Health (ELV) vs. Managed Care Peers — Medical & Policyholder Benefits Expense($M)5
37,77937,02435,61538,06538,14036,70635,31233,50032,94930,57230,54631,334
UnitedHealth Group (UNH) — Medical & Policyholder Benefits Expense($M)
75,35873,48982,04179,95878,58573,41167,03565,95765,45865,73562,231
CVS Health / Aetna (CVS) — Medical & Policyholder Benefits Expense($M)
31,48529,35833,06632,02031,31729,13529,54329,92227,85327,80322,518
The Cigna Group (CI) — Medical & Policyholder Benefits Expense($M)
8,4307,9248,2607,8427,74910,49810,1669,5279,5159,4409,280
Humana Inc. (HUM) — Medical & Policyholder Benefits Expense($M)
33,70728,72127,99127,56526,53525,38125,12025,03925,12422,782
Centene Corporation (CNC) — Medical & Policyholder Benefits Expense($M)
41,12839,02938,30341,48940,90238,80836,50331,80932,20130,76530,93230,634
Elevance Health (ELV) vs. Managed Care Peers — Consolidated Operating Income (EBIT)($M)6
1,2691,7632,0863091,2952,4253,1706731,4082,7653,0161,284
UnitedHealth Group (UNH) — Consolidated Operating Income (EBIT)($M)
7,9918,9903804,3155,1509,1197,7738,7087,8757,9317,689
CVS Health / Aetna (CVS) — Consolidated Operating Income (EBIT)($M)
4,7034,6802,112-3,2072,3813,3742,3688323,0452,2713,373
The Cigna Group (CI) — Consolidated Operating Income (EBIT)($M)
2,6762,3582,3452,5782,3061,9712,1732,5762,4122,2562,060
Humana Inc. (HUM) — Consolidated Operating Income (EBIT)($M)
1,754-8084001,0982,014-5437281,1411,236-348
Centene Corporation (CNC) — Consolidated Operating Income (EBIT)($M)
-3071,1981,861-1,745-6,954-4581,5341756651,2291,106-194
Molina Healthcare (MOH) — Consolidated Operating Income (EBIT)($M)
10614583-162137373433380467434426316
Elevance Health (ELV) vs. Managed Care Peers — Medical Claims Payable Liability($M)5
18,43818,46318,42517,08417,14817,15516,81215,74615,34615,20416,45916,111
UnitedHealth Group (UNH) — Medical Claims Payable Liability($M)
38,93039,65939,33740,18138,42737,13634,22433,95132,54734,03232,395
CVS Health / Aetna (CVS) — Medical Claims Payable Liability($M)
16,20315,40415,32915,30014,29614,56514,98414,52113,85014,38712,067
Humana Inc. (HUM) — Medical Claims Payable Liability($M)
12,6919,96710,08811,06011,45110,44011,12511,44611,72910,241
Centene Corporation (CNC) — Medical Claims Payable Liability($M)
21,49520,26220,62720,54421,49320,11719,91118,30817,99518,17318,10918,000
Molina Healthcare (MOH) — Medical Claims Payable Liability($M)
4,9884,8414,9414,8874,8444,8854,8044,6404,7324,5774,5714,204
U.S. Personal Consumption Expenditures: Health Care Services (BEA / FRED)
3,790.303,699.903,667.003,614.903,529.803,464.703,417.803,358.203,288.203,244.403,159.40
Total Consolidated Revenues (GAAP)($M)2
51,42950,47450,18149,74750,71149,77648,89145,44245,10643,88642,57742,647
Consolidated Premiums Revenue($M)
41,70441,27941,02440,69041,79141,27140,88736,24536,80935,41635,69635,138
Consolidated Net Investment Income($M)
1,037704765493625486590527551508465529
Consolidated Operating Income (DB Standardized EBIT)($M)6
1,2691,7632,0863091,2952,4253,1706731,4082,7653,0161,284
Consolidated Benefit Expense($M)
37,77937,02435,61538,06538,14036,70635,31233,50032,94930,57230,54631,334
Consolidated Cost of Products Sold($M)
5,6405,4925,4635,5225,3805,2934,9836,0125,0934,8203,8254,837
Consolidated Operating Expense (SG&A — GAAP)($M)1
5,7525,5476,3305,4155,2724,9975,3004,8045,2695,0664,8864,999
Adjusted Operating Expense (Non-GAAP)($M)
5,6845,4925,2125,3495,2234,9345,2154,6364,2184,9304,7764,925
Consolidated Depreciation and Amortization($M)
363366354406387380373398329335331424
Amortization of Other Intangible Assets($M)
106110112164162147155180122162116217
Consolidated Interest Expense($M)
358364357366351341344340300280265259
Shareholders' Net Income (GAAP)($M)3
1,3651,4631,7645471,1891,7432,1834181,0162,3002,246856
Adjusted Shareholders' Net Income (Non-GAAP)($M)1
1,5201,6242,7727391,3491,9972,7197472,0052,4052,5371,325
Non-GAAP Adj: Total Net Adjustment Items to Shareholders' Net Income($M)6
1551611,008192160254536329989105291469
Non-GAAP Adj: Amortization of Other Intangible Assets (Pre-Tax)($M)
106110112164162147155180122162116217
Non-GAAP Adj: Net Losses (Gains) on Financial Instruments (Pre-Tax)($M)
4856785711314647412585161336
Non-GAAP Adj: Transaction and Integration Related Costs (Pre-Tax)($M)
424447544953806642645259
Non-GAAP Adj: Business Optimization Charges (Pre-Tax)($M)
-34-42684-422
Non-GAAP Adj: Litigation and Settlement Expenses (Pre-Tax)($M)
8117541051266992-7
Non-GAAP Adj: Income Tax Impact of Non-GAAP Adjustments($M)
-67-60-300-95-52-87-168-93-348-38-96-158
Income Before Income Tax Expense (GAAP Pretax Income)($M)
1,7941,9372,3042151,4062,2922,7976061,3732,9862,9391,001
Consolidated Income Tax Expense($M)
451483544-331219548613193365685690170
GAAP Diluted Earnings Per Share($)5
6.276.7185.327.729.614.369.859.59
Adjusted Shareholders' Diluted EPS (Non-GAAP)($)
6.997.4512.583.336.038.8411.973.238.6010.3010.835.62
GAAP Basic Earnings Per Share($)
6.306.748.035.327.749.644.389.919.65
Diluted Weighted-Average Common Shares(M)
218218220-1224226227-0.70233233234-0.60
Basic Weighted-Average Common Shares(M)
217217220-1223225226-0.60232232233-0.50
Common Stock Dividends Declared per Share($)
1.721.721.721.711.711.711.711.631.631.631.631.48
Total Consolidated Assets($M)6
127,801126,438125,827121,494122,749121,938119,717116,889116,533112,988111,894108,928
Cash and Cash Equivalents($M)
10,34810,2329,6579,4918,7138,5607,5008,2887,8666,4976,2266,526
Premium Receivables, Net($M)
10,68610,99111,52510,0739,53510,46510,3598,0117,2098,0408,9317,902
Premiums Receivable — Allowance for Credit Losses / Doubtful Accounts($M)
180187205167168163178183185177212212
Other Receivables (Rebates, Pharmacy & Reinsurance)($M)
7,6106,8186,1676,3077,6927,2066,5766,0166,0555,8815,1205,405
Property and Equipment, Net($M)
4,6134,6454,6574,6794,6574,6414,6174,6524,5054,4504,4514,359
Goodwill($M)
28,34328,33928,34028,34428,45128,36828,42028,27725,96725,96225,94725,317
Total Shareholders' Equity($M)4
44,68144,88343,90243,88243,95343,72242,50341,31543,77542,19140,60839,306
Total Consolidated Liabilities($M)
83,00781,41681,78577,46878,66778,08777,09775,46372,65470,69171,18469,523
Unearned Income (Advance Premiums)($M)
1,6371,6401,7591,4931,8311,5611,6401,5081,7931,4811,4741,402
Retained Earnings($M)
37,36836,67535,79635,39335,58635,54934,54633,54935,15734,57533,08831,749
Accumulated Other Comprehensive Income (Loss)($M)
-1,676-711-741-451-543-760-911-1,147-489-1,387-1,365-1,313
Net Cash Provided by Operating Activities (Operating Cash Flow)($M)4
1,2671,9134,332841,1352,0541,0177062,6774471,978-2,971
Operating Cash Flow as Multiple of GAAP Net Income(×)
0.90
Purchases of Property and Equipment (CapEx)($M)
267287235293360267196322332323279326
Share-Based Compensation Expense($M)
80755530848181-2966926272
Cash Dividends Paid to Common Shareholders($M)
373373376377381385386373386378379346

8 chỉ số không có số liệu trong 12 quý gần nhất — .

In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).

Phương pháp và các chỉ số bị loại
  • Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
  • Fiscal calendar: Elevance Health, Inc. (formerly Anthem, Inc. prior to June 2022) operates on a calendar fiscal year ending December 31 (Q1 ends Mar 31, Q2 ends Jun 30, Q3 ends Sep 30, Q4 ends Dec 31). Latest reported company period: Q3 2026 (ended September 30, 2026, filed October 21, 2026 on Form 10-Q and Form 8-K) and Full-Year FY2025 (ended December 31, 2025, filed February 6, 2026 on Form 10-K).
  • 2023 Segment Realignment: Effective Q1 2023, Elevance Health reorganized its reportable segments into Health Benefits (combining Commercial & Specialty Business and Government Business), CarelonRx (formerly IngenioRx), Carelon Services (health care services, behavioral health, complex & post-acute care), and Corporate & Other. Legacy segment series (Commercial & Specialty Business, Government Business) that ended in FY2022 are recorded in excluded metrics.
  • 2024 Life & Disability Divestiture: On April 1, 2024, Elevance Health completed the sale of its Life and Disability business to StanCorp Financial Group (The Standard). Life and Disability membership (4,693 thousand members at Q1 2024) was discontinued beginning in Q2 2024 and is recorded in excluded metrics.
  • Parent-Company Schedule II Evaluation (Step 3/4): Under 17 CFR § 210.5-04, Elevance Health includes Schedule II (Condensed Financial Information of Registrant — Parent Company Only) in Form 10-K because its state-regulated insurance and HMO subsidiaries are subject to statutory Risk-Based Capital (RBC) and dividend restrictions. Because the parent registrant is a pure holding company with no direct insurance underwriting revenue ($12M intercompany service fees vs. $197,584M consolidated operating revenue in FY2025), Consolidated − Parent subtraction is not applicable under Step 3(b); instead, Group 4 presents the exact published Schedule II Parent Company figures alongside Note 21 Statutory Capital & Surplus.
  • CMS Medicaid Managed Care Enrollment (Group 6): Sourced directly from the official U.S. Centers for Medicare & Medicaid Services (CMS) Medicaid Managed Care Enrollment Reports (2016–2024). In 2024, Elevance Health rebranded several state Medicaid plans from Amerigroup to Wellpoint; state series continuously bridge Amerigroup (2016–2023) and Wellpoint (2024).
  • Strict Step 4 & Step 5 Compliance: Every cell displays a point figure published by Elevance Health or official external sources (CMS, BLS/BEA via FRED, SEC XBRL peer filings), plus permitted period subtractions from cumulative disclosures (Q4 = FY − 9M and quarterly = YTD_t − YTD_{t-1}, marked with formula). Bound/approximate range statements from narrative commentary and guidance ('at least $22.00 GAAP EPS', 'at least $29.00 Adjusted EPS', 'at least $6.5 billion operating cash flow', 'over 104 million consumers served') are excluded from numeric cells.

Không hiện vì thiếu các kỳ gần đây (6)

  • Other Membership — Life and Disability Members (discontinued in Q2 2024 following the April 1, 2024 divestiture of the Life and Disability business to StanCorp Financial Group; last reported 4,693 thousand members at Q1 2024)
  • Medical Membership — Commercial & Specialty Business Subtotal & Government Business Subtotal (legacy segment structure replaced in Q1 2023 by Health Benefits)
  • Medical Membership — Local Group, National Accounts, Self-Funded & Fully-Insured Breakdown (legacy customer/funding classification replaced in Q1 2021 by Commercial Risk-Based vs. Commercial Fee-Based)
  • Reportable Segments (Legacy) — Commercial & Specialty Business, Government Business, IngenioRx & Other (realigned in Q1 2023 into Health Benefits, CarelonRx, Carelon Services, and Corporate & Other)
  • Health Benefits & Carelon Segment Adjusted Operating Margin % (not reported in 2026 quarterly Form 8-K highlights; GAAP Segment Operating Margin % is reported continuously through Q3 2026)
  • Narrative Bound / Outlook Range Figures — Full-Year 2026 GAAP EPS ('at least $22.00'), Adjusted EPS ('at least $29.00'), Operating Cash Flow ('at least $6.5 billion'), Total Enterprise Consumers Served ('over 104 million'), and Sydney Health Digital App Members ('over 22 million')

Dữ liệu cập nhật 2026-10-28.

Mỗi KPI một trang riêng

Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số

2. Operating Segment Results & Disaggregated Revenue/Expense (Health Benefits, CarelonRx & Carelon Services)

6. State-by-State & National Medicaid Enrollment — U.S. Government Data (CMS Medicaid Managed Care Enrollment Report)

Tài liệu nguồn mới nhất

Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Elevance Health

See a number that looks wrong?